[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 685 Introduced in House (IH)]

<DOC>






119th CONGRESS
  1st Session
H. RES. 685

Expressing support for testing for antiphospholipid syndrome (APS) as a 
      standard part of prenatal screening, and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           September 9, 2025

Mrs. Cammack (for herself, Ms. Kamlager-Dove, Mrs. Kim, Ms. Pettersen, 
  Mrs. Hinson, Ms. Adams, Mrs. Cherfilus-McCormick, and Mr. Landsman) 
submitted the following resolution; which was referred to the Committee 
                         on Energy and Commerce

_______________________________________________________________________

                               RESOLUTION


 
Expressing support for testing for antiphospholipid syndrome (APS) as a 
      standard part of prenatal screening, and for other purposes.

Whereas antiphospholipid syndrome (APS) is a condition in which the immune 
        system of an individual mistakenly produces antibodies that increase the 
        risk of blood clots;
Whereas APS can increase the risk of miscarriages, stillbirths, and pregnancy 
        complications;
Whereas professional medical associations and guideline-setting bodies do not 
        recommend testing for APS as a standard part of prenatal screening;
Whereas professional medical associations and guideline-setting bodies recommend 
        testing for APS only if a woman has an unexplained fetal loss after 10 
        weeks or 3 or more unexplained embryonic losses (miscarriages);
Whereas APS is responsible for about 15 percent of recurrent pregnancy losses;
Whereas the total number of miscarriages caused by APS is unknown because it is 
        not tested as part of normal prenatal screening;
Whereas APS can be detected by a blood test and treated by blood thinners; and
Whereas testing for APS during normal prenatal screening can save babies and 
        reduce grief for women and families: Now, therefore, be it
    Resolved, That the House of Representatives--
            (1) supports testing for antiphospholipid syndrome (APS) as 
        a standard part of prenatal screening; and
            (2) calls upon professional medical associations and 
        guideline-setting bodies to update their recommendations to 
        include testing for APS as a standard part of prenatal 
        screening.
                                 <all>